157
Views
14
CrossRef citations to date
0
Altmetric
Fetal Growth

Retinol binding protein as early marker of fetal growth restriction in first trimester maternal serum

, , , , , , , & show all
Pages 323-326 | Received 24 Jun 2012, Accepted 15 Oct 2012, Published online: 25 Jan 2013

References

  • Hui L, Challis D. Diagnosis and management of fetal growth restriction: the role of fetal therapy. Best Pract Res Clin Obstet Gynaecol 2008;22:139–58
  • Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obstet Gynecol 1997;40:723–9
  • Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970–5
  • Fruscalzo A, Bertozzi S, Londero AP, et al. Menstrual abnormalities and predisposition to pregnancy-related hypertensive disorders: a retrospective study. Gynecol Endocrinol 2010;26:445–50
  • Gaetani S, Bellovino D, Apreda M, Devirgiliis C. Hepatic synthesis, maturation and complex formation between retinol-binding protein and transthyretin. Clin Chem Lab Med 2002;40:1211–20
  • Johansson S, Gustafson AL, Donovan M, et al. Retinoid binding proteins-expression patterns in the human placenta. Placenta 1999;20:459–65
  • Robbins J. Transthyretin from discovery to now. Clin Chem Lab Med 2002;40:1183–90
  • Zanotti G, Berni R. Plasma retinol-binding protein: structure and interactions with retinol, retinoids, and transthyretin. Vitam Horm 2004;69:271–95
  • Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356–62
  • Wolf G. Serum retinol-binding protein: a link between obesity, insulin resistance, and type 2 diabetes. Nutr Rev 2007;65:251–6
  • Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
  • Chauhan SP, Gupta LM, Hendrix NW, Berghella V. Intrauterine growth restriction: comparison of American College of Obstetricians and Gynecologists practice bulletin with other national guidelines. Am J Obstet Gynecol 2009;200:409 e1–6
  • Nesterenko TH, Aly H. Fetal and neonatal programming: evidence and clinical implications. Am J Perinatol 2009;26:191–8
  • Kajantie E, Eriksson JG, Osmond C, et al. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009;40:1176–80
  • Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med 2004;19:307–19
  • Mazaki-Tovi S, Romero R, Vaisbuch E, et al. Retinol-binding protein 4: a novel adipokine implicated in the genesis of LGA in the absence of gestational diabetes mellitus. J Perinat Med 2010;38:147–55
  • Laudes M, Oberhauser F, Bilkovski R, et al. Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes 2009;117:146–9
  • Vaisbuch E, Romero R, Mazaki-Tovi S, et al. Retinol binding protein 4 – a novel association with early-onset preeclampsia. J Perinat Med 2010;38:129–39
  • Shangguan X, Liu F, Wang H, et al. Alterations in serum adipocyte fatty acid binding protein and retinol binding protein-4 in normal pregnancy and preeclampsia. Clin Chim Acta 2009;407:58–61
  • Inoue S, Takamoto N, Akahori Y, et al. Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension. J Obstet Gynaecol Res 2009;35:293–300
  • Pecks U, Seidenspinner F, Rower C, et al. Multifactorial analysis of affinity-mass spectrometry data from serum protein samples: a strategy to distinguish patients with preeclampsia from matching control individuals. J Am Soc Mass Spectrom 2010;21:1699–711
  • Vascotto C, Salzano AM, D’Ambrosio C, et al. Oxidized transthyretin in amniotic fluid as an early marker of preeclampsia. J Proteome Res 2007;6:160–70
  • Raghu P, Sivakumar B. Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis. Biochim Biophys Acta 2004;1703:1–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.